[1]
|
Rashmi, R.K., Rao, S.J. and Basavaraj K.H. (2009) A comprehensive review of biomarkers in psoriasis. Clinical and Experimental Dermatology, 34, 658-663.
doi:10.1111/j.1365-2230.2009.03410.x
|
[2]
|
Schon, M.P. and Boehncke, W.H. (2005) Medical progress: Psoriasis. New England Journal of Medicine, 352, 1899-1912. http://www.nejm.org/doi/pdf/10.1056/NEJMra041320
|
[3]
|
Mazzulla, S., Chimenti, R., Sesti, S., De Stefano, S., Morrone, M. and Martino, G. (2004) Effect of sulphurous Bioglea on psoriasis. Clinica Terapeutica, 155, 499-504.
|
[4]
|
Mazzulla, S., Sesti, Martini, A., Nicoletta, V., S., De Stefano, S., Morrone, M. and Martino, G. (2011) Evaluation of natural reductants protecting red blood cell membranes against oxidative damage in psoriatic patients. Clinica Terapeutica, 162, 79-84.
http://www.seuroma.it/clinica_terapeutica/apps/autos.php?id=882
|
[5]
|
Yardley, H.J. and Summerly, R. (1981) Lipid composition and metabolism in normal and diseased epidermis. Pharmacology & Therapeutics, 13, 357-383.
doi:10.1016/0163-7258(81)90006-1
|
[6]
|
Weger, W. (2010) Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents. British Journal of Pharmacology, 160, 810-820. doi:10.1111/j.1476-5381.2010.00702.x
|
[7]
|
Pathirana, A., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Nast, A. et al. (2009) European S3-Guidelines on the systemic treatment of psoriasis vulgaris. Journal of the European Academy of Dermatology and Venereology, 23, S5-S70. doi:10.1111/j.1468-3083.2010.03671.x
|
[8]
|
Smith, C.H., Anstey A.V., Barker, J.N.W.N., Burden, A.D., Chalmers, R.J.G, Chandler, D., et al. (2009). British Association of Dermatologists guidelines for biologic interventions for psoriasis. British Journal of Dermatology, 161, 987-1019.
doi:10.1111/j.1365-2133.2009.09505.x
|
[9]
|
Nagy Papp, K.A., Dekoven, J., Parsons, L., Pirzada, S., Robern, M., Robertson, L. and Tan, J.K. (2012) Biologic therapy in psoriasis: Perspectives on associated risks and patient management. Journal of Cutaneous Medicine and Surgery, 16, 153-168.
|
[10]
|
Lukács, G.K., Sziray, A., Fazekas, K., Florián, A., Tamási, L. and Károlyi, Z. (2011). Adverse events during biological therapy-focusing on dermatological effects. Orvosi Hetilap, 152, 212-220.
|
[11]
|
Ohshima, H., Kinoshita, S., Oyobikawa, M., Futagawa, M., Takiwaki, H., Ishiko, A. and Kanto, H. (2012) Use of Cutometer area parameters in evaluating age-related changes in the skin elasticity of the cheek. Skin Research and Technology, 19, 238-242.
doi:10.1111/j.1600-0846.2012.00634.x
|
[12]
|
Tronnier, H., Wiebusch, M. and Heinrich, U. (2008) Change in skin physiological parameters in space-report on and results of the first study on man. Skin Pharmacology and Physiology, 21, 283-292.
doi:10.1159/000148045.
|
[13]
|
Dobrev, H. (2000) In vivo study of skin mechanical properties in psoriasis vulgaris. Acta Dermato-Venereologica, 80, 263-266. doi:10.1080/000155500750012135
|
[14]
|
Ellis, C.N., Gorsulowsky, D.C., Hamilton, T.A., Billings, J.K., Brown, M.D., Headington, J.T., et al. (1986), Cyclosporine improves psoriasis in a double-blind study. JAMA, 256, 3110-3116.
doi:10.1001/jama.1986.03380220076026
|
[15]
|
Toichi, E., Torres, G., McCormick, T.S., Chang, T., Mascelli, M.A., Kauffmann C.L., et al. (2006). An antiIL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. Journal of Immunology, 177, 4917-4926.
|
[16]
|
Liu, Y., Krueger, J.G. and Bowcock, A.M. (2007) Psoriasis: Genetic associations and immune system changes. Genes & Immunity, 8, 1-12. doi:10.1038/sj.gene.6364351
|
[17]
|
Nickoloff, B.J., Qin, J.Z. and Nestle, F.O. (2007). Immunopathogenesis of psoriasis. Clinical Reviews in Allergy and Immunology, 33, 45-56.
doi:10.1007/s12016-007-0039-2
|
[18]
|
Nestle, F.O., Kaplan, D.H. and Barker, J. (2009). Psoriasis. New England Journal of Medicine, 361, 496-509.
doi:10.1056/NEJMra0804595
|
[19]
|
Valitutti, S., Castellino, F. and Musiani, P. (1990) Effect of sulfurous (thermal) water on T lymphocyte proliferative response. Annals of Allergy, 65, 463-468.
|
[20]
|
Celerier, P., Richard, A., Litoux, P. and Dreno, B. (1995) Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines. Archives of Dermatological Research, 287, 680-682.
doi:10.1007/BF00371742
|
[21]
|
Magitz, H., Orion, E. and Wof, R. (2003) Balneotherapy in dermatology. Dermatologic Therapy, 16, 132-140.
doi:10.1046/j.1529-8019.2003.01622.x
|
[22]
|
Sainte-Laudy, J. (1987) Etude du pouvoir anti-degranulant de l’eau d’Avene vis-à-vis de basophiles humains sensibilièe. International Journal of Immunotherapy, 4, 307-312.
|
[23]
|
Nasermoaddeli, A. and Kagamimori, S. (2005), Balneotherapy in medicine: A rewiew. Environmental Health and Preventive Medicine, 10, 171-179.
doi:10.1007/BF02897707
|
[24]
|
Mirandola, P., Gobbi, G., Sponzilli, I. and Pambianco, M. (2007) Exogenous hydrogen sulfide induces functional inhibition and cell death of cytotoxic lymphocytes subsets. Journal of Cellular Physiology, 213, 826-833.
doi:10.1002/jcp.21151
|
[25]
|
Dobrev, H. (1999) In vivo study of skin mechanical properties in patients with systemic sclerosis. Journal of the American Academy of Dermatology, 40, 436-442.
doi:10.1016/S0190-9622(99)70494-9
|
[26]
|
Dobrev, H. (1998) In vivo study of skin mechanical properties in scleredema of Buschke. Acta Dermato-Venereologica, 78, 103-106. doi:10.1080/000155598433412
|
[27]
|
Dobrev, H. (2000) Use of cutometer to assess epidermal hydration. Skin Research and Technology, 6, 239-244.
doi:10.1034/j.1600-0846.2000.006004239.x
|
[28]
|
Ryu, H.S., Joo, Y.H., Kim, S.O., Park, K.C. and Youn, S.W. (2008) Influence of age and regional differences on skin elasticity as measured by the Cutometer?. Skin Research and Technology, 14, 354.
doi:10.1111/j.1600-0846.2008.00302.x
|